0000887733FALSE1340 Treat Boulevard, Suite 600Walnut CreekCalifornia00008877332025-02-182025-02-180000887733us-gaap:CommonStockMember2025-02-182025-02-180000887733us-gaap:CommonClassAMember2025-02-182025-02-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 of 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
February 18, 2025
CENTRAL_GARDEN & PET_B_Lge - Cropped.jpg
Central Garden & Pet Company
(Exact name of registrant as specified in its charter)
Delaware
001-33268
68-0275553
(State or other jurisdiction
of incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)
1340 Treat Boulevard, Suite 600, Walnut Creek, California
94597
(Address of principal executive offices) (Zip Code)
(925) 948-4000
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
CENT
The NASDAQ Stock Market LLC
Class A Common Stock
CENTA
The NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers
Fiscal 2024 Bonus Determinations
On February 11, 2025, the Compensation Committee (the “Compensation Committee”) of the Board of Directors of the Company (the
“Board”) approved cash bonus payments to the Company’s named executive officers for fiscal 2024. This bonus compensation information
was not included in the Summary Compensation Table included in the Company’s Proxy Statement for its 2025 Annual Meeting of
Shareholders, filed with the Securities and Exchange Commission (the “SEC”) on December 30, 2024 (the “Proxy Statement”), because the
amount of the bonuses had not been determined at the time of filing the Proxy Statement. In accordance with Item 5.02(f), the table below
updates the Non-Equity Incentive Plan Compensation and Total columns in the fiscal 2024 summary compensation table for the named
executive officers previously set forth in the Proxy Statement.  No other amounts have changed.
SUMMARY COMPENSATION TABLE
Name and Principal Position
Year
Salary
($)(4)
Bonus
($)
Stock
Awards (5)($)
Option
Awards
(6)($)
Non-Equity Incentive
Plan Compensation
($)
All Other
Compensation 
(7)($)
Total
($)
Timothy P. Cofer
Former Chief Executive
Officer(1)
2024
88,638
—
—
—
—
6,633
95,271
2023
1,080,902
—
2,299,977
614,800
—
2,620,159
6,615,838
2022
1,017,308
—
3,199,970
—
581,175
2,407,971
7,206,424
Mary Beth Springer
Former Interim Chief Executive
Officer(2)
2024
934,737
—
120,019
—
920,000
1,019
1,975,775
Nicholas Lahanas
Chief Executive Officer and
Former Chief Financial Officer(3)
2024
522,568
—
396,971
—
245,000
11,746
1,176,285
2023
508,669
—
249,998
—
222,000
11,685
992,352
2022
478,662
—
249,983
—
125,400
10,426
864,471
John Hanson
President, Pet Consumer
Products
2024
537,505
—
246,966
—
341,000
45,893
1,171,364
2023
545,838
—
249,998
—
328,000
48,113
1,171,949
2022
513,716
—
249,983
—
135,300
100,112
999,111
John D. Walker
President, Garden Consumer
Products
2024
550,714
—
246,966
—
167,000
42,745
1,007,425
2023
559,000
—
249,998
—
136,000
43,735
988,733
2022
525,519
—
249,983
—
127,100
38,098
940,700
William E. Brown
Chairman of the Board of
Directors
2024
300,000
—
444,592
—
132,000
26,359
902,951
2023
311,538
—
449,996
—
99,000
22,671
883,205
2022
289,845
—
450,028
—
81,000
24,008
844,881
__________________________
(1)Mr. Cofer resigned as our Chief Executive Officer effective October 6, 2023.
(2)Upon Mr. Cofer’s resignation as our Chief Executive Officer, Ms. Springer was appointed Interim Chief Executive Officer and served in that capacity from October 6,
2023 to September 29, 2024.
(3)Mr. Lahanas resigned as our Chief Financial Officer effective September 28, 2024, and was appointed as Chief Executive Officer effective as of September 29,
2024. Upon Mr. Lahanas’s resignation as Chief Financial Officer, Bradley G. Smith was appointed as Chief Financial Officer effective as of September 29, 2024, the
first day of the 2025 fiscal year.
(4)The amount for Mr. Cofer includes prorated salary of $40,290 and accrued paid time off of $48,348.
(5)This column represents the grant date fair value in accordance with ASC 718 of restricted stock and PSUs awarded the named executive officers in fiscal 2024. The
amounts shown include the aggregate grant date fair value of the shares issuable for PSUs at target achievement. The aggregate grant date fair values of the
maximum number of shares issuable pursuant to the PSUs are $277,845 for each of Messrs. Lahanas, Hanson, and Walker. These amounts do not represent the
actual value that may be realized by the named executive officers.
(6)This column represents the grant date fair value in accordance with ASC 718. Please refer to Note 14, “Stock-Based Compensation”, in the Notes to Consolidated
Financial Statements included in our Annual Report on Form 10-K filed on November 27, 2024 for the relevant assumptions used to determine the compensation
cost of our stock option awards. These amounts do not represent the actual value, if any, that may be realized by the named executive officers.
(7)The components of the “All Other Compensation” column for fiscal 2024 are detailed in the following table:
Description
Timothy P. Cofer
Mary Beth Springer
Nicholas Lahanas
John Hanson
John D. Walker
William E. Brown
Company matching contribution
to 401(k) plan ..........................................................
$            —
$            —
$          10,350
$            10,350
$      10,350
$        9,000
Medical insurance premiums and medical reimbursement .....................
2,359
53
106
21,173
21,147
17,038
Group term life insurance ................................................
58
966
1,290
1,290
1,648
321
Car allowance or lease ...................................................
3,300
—
—
12,000
9,600
—
Mobile device ..........................................................
—
—
—
1,080
—
—
Relocation .............................................................
            916
            —
            —
            —
            —
            —
Total
$6,633
$1,019
$11,746
$45,893
$42,745
$26,359
In addition, the Compensation Committee approved an increase in Mr. Hanson’s base salary to $568,000, Mr. Walker’s base salary to
$567,000, and Mr. Brown’s base salary to $309,000. The increases were effective as of January 1, 2025.
On February 11, 2025, the Board approved grants of restricted stock and performance stock units to certain executive officers under the
Company’s 2003 Omnibus Equity Incentive Plan, pursuant to the form of agreements previously filed as exhibits to the Company’s filings with
the SEC.
Item 5.07Submission of Matters to a Vote of Security Holders
On February 12, 2025, at the 2025 Annual Meeting of Shareholders (the “Annual Meeting”), the following proposals were submitted to the
shareholders:
a.The election of ten directors to serve until the 2026 Annual Meeting and until their successors are duly elected and qualified.
b.The ratification of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending
on September 27, 2025.
The Board withdrew Proposal Three to approve an amendment to the Company’s Fourth Amended and Restated Certificate of Incorporation
to include an officer exculpation provision prior to the Annual Meeting as described in the Company’s Supplement to the Proxy Statement
filed on February 11, 2025 with the SEC.
For more information about the foregoing proposals, see the Proxy Statement, the relevant portions of which are incorporated herein by
reference. Holders of the Company’s Common Stock are entitled to one vote per share and holders of the Company’s Class B Stock are
entitled to the lesser of ten votes per share or 49% of the total votes cast.  Holders of the Company’s Common Stock and holders of the
Company’s Class B Stock vote together as a single class on all matters (including the election of directors) submitted to a vote of
stockholders, unless otherwise required by law. The number of votes cast for and withheld/against and the number of abstentions and broker
non-votes with respect to each matter voted upon are set forth below:
Proposal One:
The following individuals were elected to serve as directors until the Company’s next annual meeting and until their respective successors are
elected and qualified by the votes set forth in the following table:
Director Nominee
For
Withheld
Broker Non-Votes
William E. Brown .............................................
16,925,852
2,375,926
272,907
Courtnee Chun ...............................................
17,044,727
2,257,051
272,907
Lisa Coleman .................................................
17,044,514
2,257,264
272,907
Brendan P. Dougher ........................................
17,044,494
2,257,284
272,907
Nicholas Lahanas ...........................................
17,271,306
2,030,472
272,907
Randal D. Lewis ..............................................
19,273,003
28,775
272,907
Christopher T. Metz .........................................
13,980,186
5,321,592
272,907
Brooks M. Pennington III ..................................
17,002,649
2,299,129
272,907
John R. Ranelli ...............................................
17,016,381
2,285,397
272,907
Mary Beth Springer .........................................
16,873,381
2,428,397
272,907
Proposal Two:
The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending on
September 27, 2025 was ratified, by the votes set forth in the following table:
For
Against
Abstain
Broker Non-Votes(1)
19,566,205
268,191
1,272
0
(1)  Pursuant to the rules of the New York Stock Exchange, this proposal constituted a routine matter.  Therefore, brokers were permitted to vote without receipt of instructions
from beneficial owners.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
CENTRAL GARDEN & PET COMPANY
By:    /s/ Joyce M. McCarthy
Joyce M. McCarthy
General Counsel and Secretary
Dated:  February 18, 2025
v3.25.0.1
Cover
Feb. 18, 2025
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Feb. 18, 2025
Entity Registrant Name Central Garden & Pet Company
Entity Incorporation, State or Country Code DE
Entity File Number 001-33268
Entity Tax Identification Number 68-0275553
Entity Address, Postal Zip Code 94597
City Area Code (925)
Local Phone Number 948-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000887733
Amendment Flag false
Entity Address, Address Line One 1340 Treat Boulevard, Suite 600
Entity Address, City or Town Walnut Creek
Entity Address, State or Province CA
Common Stock  
Document Information [Line Items]  
Title of 12(b) Security Common Stock
Trading Symbol CENT
Security Exchange Name NASDAQ
Common Class A  
Document Information [Line Items]  
Title of 12(b) Security Class A Common Stock
Trading Symbol CENTA
Security Exchange Name NASDAQ
Central Garden and Pet (NASDAQ:CENTA)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Central Garden and Pet Charts.
Central Garden and Pet (NASDAQ:CENTA)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Central Garden and Pet Charts.